AnalystsRobert LeBoyer
Robert LeBoyer's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 15%
#4233 out of 4929 analysts
Average Return
-3.61%
Win Rate
33%5 out of 15
Risk vs Reward
Poor
Good

Robert LeBoyer's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Anavex Life Sciences CorpAVXL
+302.15%$4.66$18.74
2020-09-27 -
2021-09-24
Strong Buy
Eledon Pharmaceuticals IncELDN
+101.59%$1.26$2.54
2023-09-26 -
2024-09-26
Buy
Tonix Pharmaceuticals Holding CorpTNXP
+95.05%$18.19$35.48
2025-03-19 -
2025-07-03
Buy
Cadrenal Therapeutics IncCVKD
+58.70%$7.22$11.45
2023-12-17 -
2024-12-17
Buy
Nutriband IncNTRB
+35.01%$7.34$9.91
2025-01-21 -
2025-07-03
Buy

Robert LeBoyer Analyst Color

Get additional color on Robert LeBoyer's coverage of popular stocks

Robert LeBoyer's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Tonix Pharmaceuticals Holding CorpTNXP
2Buy$70.00+97.29%Reiterates
3 months ago
Nutriband IncNTRB
1Buy$13.00+31.18%Initiates Coverage On
5 months ago
Geovax Labs IncGOVX
2Buy$10.00+1,983.33%Maintains
a year ago
Unicycive Therapeutics IncUNCY
1Buy$60.00N/AInitiates Coverage On
a year ago
Cadrenal Therapeutics IncCVKD
1Buy$60.00N/AInitiates Coverage On
2 years ago
Eledon Pharmaceuticals IncELDN
1Buy$10.00N/AInitiates Coverage On
2 years ago
Maia Biotechnology IncMAIA
1Buy$14.00N/AInitiates Coverage On
2 years ago
Ayala Pharmaceuticals IncAYLA
1HoldN/AN/ADowngrades
3 years ago
Axcella Health IncAXLA
1Buy$150.00N/AInitiates Coverage On
4 years ago
Plus Therapeutics IncPSTV
1Strong Buy$120.00N/AInitiates Coverage On
4 years ago
Anavex Life Sciences CorpAVXL
1Strong Buy$12.00N/AInitiates Coverage On
5 years ago
Cns Pharmaceuticals IncCNSP
1Strong Buy$16,500.00N/AInitiates Coverage On
5 years ago
Vtv Therapeutics IncVTVT
1HoldN/AN/ADowngrades
7 years ago
Neurotrope IncNTRP1
2Strong Buy$15.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.